Campbell & Co Investment Adviser’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,292
Closed -$430K 1100
2024
Q3
$430K Buy
+9,292
New +$430K 0.03% 771
2024
Q1
Sell
-32,578
Closed -$1.06M 1137
2023
Q4
$1.06M Buy
32,578
+22,548
+225% +$732K 0.1% 363
2023
Q3
$273K Sell
10,030
-13,320
-57% -$363K 0.03% 747
2023
Q2
$520K Buy
23,350
+3,910
+20% +$87K 0.09% 421
2023
Q1
$421K Sell
19,440
-44,688
-70% -$968K 0.08% 489
2022
Q4
$1.3M Buy
64,128
+27,211
+74% +$553K 0.31% 48
2022
Q3
$947K Buy
36,917
+17,875
+94% +$459K 0.22% 139
2022
Q2
$453K Sell
19,042
-34,458
-64% -$820K 0.12% 310
2022
Q1
$1.21M Buy
+53,500
New +$1.21M 0.32% 52
2021
Q4
Sell
-16,200
Closed -$319K 640
2021
Q3
$319K Buy
16,200
+1,550
+11% +$30.5K 0.1% 358
2021
Q2
$322K Buy
14,650
+2,950
+25% +$64.8K 0.13% 299
2021
Q1
$278K Buy
+11,700
New +$278K 0.17% 251
2020
Q4
Sell
-29,487
Closed -$513K 440
2020
Q3
$513K Buy
+29,487
New +$513K 0.38% 68
2020
Q1
Sell
-64,508
Closed -$781K 127
2019
Q4
$781K Buy
+64,508
New +$781K 0.24% 97
2017
Q4
Sell
-23,300
Closed -$450K 411
2017
Q3
$450K Buy
23,300
+8,770
+60% +$169K 0.36% 76
2017
Q2
$171K Sell
14,530
-83
-0.6% -$977 0.16% 283
2017
Q1
$160K Sell
14,613
-1,498
-9% -$16.4K 0.41% 119
2016
Q4
$117K Sell
16,111
-5,335
-25% -$38.7K 0.36% 116
2016
Q3
$139K Buy
21,446
+5,652
+36% +$36.6K 0.37% 118
2016
Q2
$86K Buy
+15,794
New +$86K 0.43% 78